Patents/Assignees

Lamkap Bio Gamma AG

1 patent in portfolio

US12122850utility2024
Bispecific Gpc3xcd28 and Gpc3xcd3 Antibodies and Their Combination for Targeted Killing of GPC3 Positive Malignant Cells
0 cites